These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4699091)

  • 21. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer.
    Ochoa L; Igartua M; Hernández RM; Gascón AR; Pedraz JL
    J Pharm Pharm Sci; 2005 Jun; 8(2):132-40. PubMed ID: 16124924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Manufacturing delayed action tablet using sugar cane wax].
    Orbán E; Isaura LV
    Acta Pharm Hung; 1973 Jan; 43(1):9-13. PubMed ID: 4687825
    [No Abstract]   [Full Text] [Related]  

  • 23. [Peroral, compounded long-acting drugs. 3. Tablets coated with Eudragite retard].
    Chalabala M; Starha L
    Cesk Farm; 1970 Jun; 19(5):184-6. PubMed ID: 5448541
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of gastric banding on pharmacotherapy: not much known].
    Wilting I; van den Bemt PM; Brenninkmeijer SJ; Spooren PF; Siemons AA; Egberts AC
    Ned Tijdschr Geneeskd; 2007 May; 151(20):1112-5. PubMed ID: 17557666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of dissolution induced changes in film coat composition by 1H NMR spectroscopy and SEM.
    Strübing S; Metz H; Syrowatka F; Mäder K
    J Control Release; 2007 Jun; 119(2):190-6. PubMed ID: 17434640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ibuki R; Higaki K; Kimura T
    J Control Release; 2006 May; 112(1):51-6. PubMed ID: 16545477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymer-coated microparticles for the sustained release of nitrofurantoin.
    Liu J; Chan SY; Ho PC
    J Pharm Pharmacol; 2002 Sep; 54(9):1205-12. PubMed ID: 12356274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ulcerogenic properties of enteric coated compounds in dogs.
    Stahlgren LH; Dapena A; Roy RL
    Surg Forum; 1965; 16():367-8. PubMed ID: 5888407
    [No Abstract]   [Full Text] [Related]  

  • 32. Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.
    Zmeili S; Hasan M; Najib N; Sallam E; Deleq S; Shubair M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):564-70. PubMed ID: 8996854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coating of pharmaceuticals by phase separation of cellulose derivatives: preparation and in-vitro release.
    Khalil SH; el-Gamal SS
    Pharmazie; 1973 Jun; 28(6):385-8. PubMed ID: 4726397
    [No Abstract]   [Full Text] [Related]  

  • 35. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
    Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
    Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Advances in research on in vivo-in vitro correlation of sustained-release oral dosage forms in traditional Chinese medicine].
    Chen LH; Xu DS; Feng Y
    Zhongguo Zhong Yao Za Zhi; 2008 Feb; 33(3):333-8. PubMed ID: 18536476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of solid dispersions of nifedipine with enteric coating agent to prepare a sustained-release dosage form.
    Hasegawa A; Nakagawa H; Sugimoto I
    Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1615-9. PubMed ID: 4042237
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drugs that should not be triturated].
    Fernández Contreras V
    Rev Enferm; 1992; 15(167-168):22-4. PubMed ID: 1641559
    [No Abstract]   [Full Text] [Related]  

  • 39. In vivo pharmacodynamic evaluation of oral dosage forms by whole body liquid scintillometry.
    Hecht G; Christian JE; Banker GS
    J Pharm Sci; 1966 Jul; 55(7):678-84. PubMed ID: 5967745
    [No Abstract]   [Full Text] [Related]  

  • 40. [Concerning the article: "A propos of 4 cases of potassium enteropathy" by H. Diserens, Ph. Gertsch, S. Schneider and R. Mosimann, Schweiz. med. Wschr. 107 1195-8 (1977)].
    Denereaz A; Vandierendounck E
    Schweiz Med Wochenschr; 1978 Jul; 108(27):1041. PubMed ID: 663599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.